Mary Rinella, MD
Enriched profileProfessor of Medicine, Gastroenterology, Hepatology and Nutrition · University of Chicago
Mary Rinella is Professor of Medicine, Gastroenterology, Hepatology and Nutrition at University of Chicago. OpenAlex indexes 279 publications with 48,331 citations (h-index 71); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Gastroenterology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Mary E. Rinella, MD, is Professor of Medicine, Gastroenterology, Hepatology and Nutrition at University of Chicago (Pritzker School of Medicine / UChicago Medicine). The public record shows 279 publications with 48,331 citations (h-index 71), centered on Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, Diet, Metabolism, and Disease. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 10 companies, 2 NIH-funded awards (2006–2011).
- Most recent indexed publication: 2026 · Hepatology communications
- Top research focus: Liver Disease Diagnosis and Treatment
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 137.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Sponsor: University of Chicago
- Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation
Sponsor: Northwestern University
Industry payments
Updated 27 Aug 2026
10 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20257 payments$23,631openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim International GmbHProgram year202510 payments$20,568openpaymentsdata.cms.gov ↗
- Madrigal PharmaceuticalsProgram year202514 payments$19,314openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
66.7%Bile Acid32.6%Ursodiol100%Part D≥14 patientsRifamycin Antibacterial15.6%Xifaxan100%Part D<11 patientsCardiovascular
19.9%Aldosterone antagonist (MRA)11.3%Spironolactone100%Part D<11 patientsBeta blocker8.5%Carvedilol100%Part D<11 patientsCancer & immunology
13.5%Purine Antimetabolite13.5%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
2 NIH research awards on record, funded 2006–2011 per NIH RePORTER. The latest:
- Mechanisms of Non-Alcoholic Steatohepatitis
Northwestern University at Chicago
FY2011$126,144K08DK066032 - Mechanisms of Non-Alcoholic Steatohepatitis
Northwestern University at Chicago
FY2010$126,144K08DK066032 - Mechanisms of Non-Alcoholic Steatohepatitis
Northwestern University at Chicago
FY2009$126,144K08DK066032
Congress activity
Updated 27 Aug 2026
1 congress contribution (2025) across ADA per OpenAlex. The most recent:
- 1368-P: A Prediction Model for Prediabetes and Diabetes Using Easily Obtainable Clinical Data
ADA Scientific Sessions
ADA2025Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trial.
Hepatology communications
Article2026 - The economic burden of MASH: comparison of healthcare resource utilization and costs in patients with probable MASH, without MASH, and with diagnosed MASH.
Expert review of pharmacoeconomics & outcomes research
Article2026 - Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management.
Nature reviews. Gastroenterology & hepatology
Review2026 - Practical Considerations for the Use of Semaglutide in MASH.
The American journal of gastroenterology
Article2026 - Response to "Aspirin for Primary Prevention in Metabolic Dysfunction-Associated Steatotic Liver Disease".
Hepatology research
Letter2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Mechanisms of NAFLD development and therapeutic strategies4,252 citations2018
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- X / Twitter
x.com/marurinella
Mentions by others
where others cite or feature them- Other
aasld.org/governing-board/mary-e-mccarthy-rinella-md-faasld
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗ - Other
aasld.org/liver-fellow-network/core-series/podcast/whats-new-nash-mary-rinella
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Illinois College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗ - Internal Medicine Residency
University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Fellowship
Gastroenterology and Hepatology, Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uchicagomedicine.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uchicagomedicine.org ↗
Editorial & leadership roles
journal and society appointments- Lead author/Chair
2023 AASLD Clinical Practice Guidance on diagnosis and management of NAFLD/MASLD
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗ - Director
Metabolic and Fatty Liver Program, University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗ - Director of Clinical Trials
Section of Gastroenterology, Hepatology and Nutrition, University of Chicago
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.uchicago.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bucksbauminstitute.uchicago.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Secondary affiliations
appointments beyond the home institution- Bucksbaum-Siegler Institute for Clinical Excellence
University of Chicago (Master Clinician program member)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bucksbauminstitute.uchicago.edu ↗
Media & interviews
press, podcasts and appearances- Podcast: "What's New in NASH with Mary Rinella"
AASLD Liver Fellow Network / Liver Talks podcast, discussing the 2023 AASLD NASH Clinical Practice Guidance
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hcplive.com ↗
- Featured expert
UChicago Medicine Forefront article on NAFLD/MASLD renaming ("Fatty liver disease gets a new name")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uchicagomedicine.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Everett Vokes, MD
University of Chicago
Ralph Weichselbaum, MD
University of Chicago
Hedy Kindler, MD
University of Chicago
Samuel Refetoff, MD
University of Chicago